| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/26/2011 | WO2011060789A2 Treatment of acute ischemic stroke or intracranial bleeding with tpa and carbamylated erythropoietin |
| 05/26/2011 | WO2011060613A1 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof |
| 05/26/2011 | WO2011060583A1 Nonnatural collagen-like protein and use thereof |
| 05/26/2011 | WO2011060534A1 Trim5alpha mutants and uses thereof |
| 05/26/2011 | WO2011060489A1 Transgenic non-human animals |
| 05/26/2011 | WO2011039584A3 Parstatin peptides |
| 05/26/2011 | WO2011038397A3 Peptide adjuvants, vaccines, and methods of use |
| 05/26/2011 | WO2011028406A3 Soaking agent for the treatment of hemorrhoids and method of use |
| 05/26/2011 | WO2011024079A3 Peptoid agonists of nerve growth factor and their use as medicaments |
| 05/26/2011 | WO2011019221A3 Agent for stimulating mobilization of endothelial progenitor cells |
| 05/26/2011 | WO2011016026A3 Novel proteins |
| 05/26/2011 | WO2011014872A3 Compositions and methods for diagnosing, treating or preventing neoplasias |
| 05/26/2011 | WO2011009042A3 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions |
| 05/26/2011 | WO2011008996A3 Peptides whose uptake in cells is controllable |
| 05/26/2011 | WO2011005380A3 Arg-gly-asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 05/26/2011 | WO2011003064A9 Methods of treating neuropathic pain |
| 05/26/2011 | WO2010151755A3 TREATMENT OF INFLAMMATORY DISEASES USING miR-124 |
| 05/26/2011 | WO2010148253A3 Formulations for lysosomal enzymes |
| 05/26/2011 | WO2010144711A3 Immunological targeting of pathological tau proteins |
| 05/26/2011 | WO2010120541A3 Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
| 05/26/2011 | WO2010118424A3 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| 05/26/2011 | WO2009080313A3 Early administration of botulinum toxin in the treatment of cerebrovascular event and spinal cord injury |
| 05/26/2011 | US20110126303 Modified Blood Clotting Factors And Methods Of Use |
| 05/26/2011 | US20110126302 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 05/26/2011 | US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging |
| 05/26/2011 | US20110125187 Light Activated Composite Tissue Adhesives |
| 05/26/2011 | US20110125089 Hemostatic microspheres |
| 05/26/2011 | US20110124853 Conjugates and Compositions for Cellular Delivery |
| 05/26/2011 | US20110124715 Antiviral Oligonucleotides Having a Conserved G4 Core Sequence |
| 05/26/2011 | US20110124585 Dimeric Small Molecule Potentiators of Apoptosis |
| 05/26/2011 | US20110124584 Compositions and methods for treating diseases |
| 05/26/2011 | US20110124583 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 05/26/2011 | US20110124582 Novel polypeptide having anti-tumor activity |
| 05/26/2011 | US20110124580 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/26/2011 | US20110124579 Sialic acid to support salivation |
| 05/26/2011 | US20110124578 Amino acid inhibitors of cytochrome p450 |
| 05/26/2011 | US20110124577 Preparation for oral administration comprises quercetin glycoside and a water-based solvent extract of cartilage containing chondroitin sulfate |
| 05/26/2011 | US20110124576 Transferrin Variants and Conjugates |
| 05/26/2011 | US20110124575 Method for processing microbiologically produced cyclic oligopeptides |
| 05/26/2011 | US20110124574 Restoration of estrogen receptor-(alpha) activity |
| 05/26/2011 | US20110124573 Osmoprotective Complexes for Prevention of Intra-cellular Dehydration in Mammals |
| 05/26/2011 | US20110124572 Syndecan-4 is a regulator of rac1-gtp |
| 05/26/2011 | US20110124571 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases |
| 05/26/2011 | US20110124570 Fish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 05/26/2011 | US20110124569 Macrocyclic compounds, protease inhibition, and methods of treatment |
| 05/26/2011 | US20110124568 Use of heat-shock protein 27 for cardiovascular disease prevention and treatment |
| 05/26/2011 | US20110124567 Therapeutic compounds and methods |
| 05/26/2011 | US20110124566 Anti-tumor fibrillar human serum albumin methods and compositions |
| 05/26/2011 | US20110124565 Modified Coagulation Factor VIII With Enhanced Stability and Its Derivatives |
| 05/26/2011 | US20110124564 Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same |
| 05/26/2011 | US20110124563 Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof |
| 05/26/2011 | US20110124562 Apoaequorin-containing compositions and methods of using same |
| 05/26/2011 | US20110124561 Use of a neuregulin to treat peripheral nerve injury |
| 05/26/2011 | US20110124560 Foxp3 oligomerization and intermolecular interactions |
| 05/26/2011 | US20110124559 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/26/2011 | US20110124558 Novel uses of d-mannopyranose derivatives activating angiogenesis |
| 05/26/2011 | US20110124557 Blood sugar-modulating polypeptides |
| 05/26/2011 | US20110124556 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 05/26/2011 | US20110124555 Use of somatostatin analogs in control of hypoglycemia |
| 05/26/2011 | US20110124554 Fibrosuppressant Biotherapeutics |
| 05/26/2011 | US20110124553 Insulin-oligomer conjugates, formulations and uses thereof |
| 05/26/2011 | US20110124552 GMCSF and Truncated CCL2 Conjugates and Methods and Uses Thereof |
| 05/26/2011 | US20110124551 Formulations of daptomycin |
| 05/26/2011 | US20110124550 Thymosin beta 4 promotes wound repair |
| 05/26/2011 | US20110124081 Nuclear factor of activated t cells receptor |
| 05/26/2011 | US20110123998 Materials and Methods for Treatment of Cancer |
| 05/26/2011 | US20110123654 Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| 05/26/2011 | US20110123638 Method for the intradermal delivery of substances |
| 05/26/2011 | US20110123634 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123633 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123625 Compositions of Less Immunogenic and Long-Circulating Protein-Lipid Complexes |
| 05/26/2011 | US20110123624 Formulations comprising aminosterols |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123611 Peptidyl diacylglycerides |
| 05/26/2011 | US20110123605 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123602 Molecular lymphatic mapping of sentinel lymph nodes |
| 05/26/2011 | US20110123601 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery |
| 05/26/2011 | US20110123593 Self-fixating scaffolds |
| 05/26/2011 | US20110123591 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 05/26/2011 | US20110123577 Method Of Delivering Stable Topical Drug Compositions |
| 05/26/2011 | US20110123573 Methods and compositions for treating phenylketonuria |
| 05/26/2011 | US20110123572 Activated fibroblasts for treating tissue and/or organ damage |
| 05/26/2011 | US20110123566 Endogenous adjuvant molecules and uses thereof |
| 05/26/2011 | US20110123565 Structural Proteins of Fish Pancreatic Disease Virus and Uses Thereof |
| 05/26/2011 | US20110123558 Peptide with Reduced Dimer Formation |
| 05/26/2011 | US20110123551 Hvem/btla, hvem/cd 160 and hvem/gd cis complexes and methods of use |
| 05/26/2011 | US20110123548 Compositions and methods for the treatment and diagnosis of immune disorders |
| 05/26/2011 | US20110123543 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 05/26/2011 | US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 05/26/2011 | US20110123538 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease |
| 05/26/2011 | US20110123535 Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival |
| 05/26/2011 | US20110123534 Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
| 05/26/2011 | US20110123530 Compositions and methods for treating and diagnosing asthma |
| 05/26/2011 | US20110123526 Methods and compositions for preventing adhesion |
| 05/26/2011 | US20110123524 Methods for treating hematopoietic malignancies |
| 05/26/2011 | US20110123521 Methods for modulating expression of rbp4 |
| 05/26/2011 | US20110123520 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| 05/26/2011 | US20110123519 Recombinant antigen |
| 05/26/2011 | US20110123517 Dissolvable pharmaceutical implant |
| 05/26/2011 | US20110123516 Nitrogenated derivatives of pancratistatin |